Gottlieb, A. B.; Armstrong, A. W.; Merola, J. F.; Napoli, A. .; Nowak, M.; Banerjee, S.; Lehman, T.; Mease, P. J. Impact of Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, Deucravacitinib, on Psoriasis in Patients With Active Psoriatic Arthritis: Results from a Phase 2 Trial. J of Skin 2024, 8, s383.